- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT00386035
Effects of Two Anti-HIV Drug Regimens on HIV Transmission Risk Behavior Among SMART Study Participants
HIV Transmission Risk Behavior Substudy
연구 개요
상세 설명
It is important to consider the role that HIV infected individuals play in ongoing HIV transmission. Different anti-HIV treatment regimens may lead to variations in HIV transmission risk behavior among HIV infected individuals. HIV infected people with viral loads of less than 1,000 copies/ml are less likely to transmit HIV through heterosexual sex. However, condom use sometimes decreases after individuals start combination antiretroviral therapy (ART); also, some studies have shown an increased rate in acquiring sexually transmitted infections (STIs) following initiation of ART, and those on ART may transmit a drug-resistant strain of HIV. In the SMART study, participants were randomly assigned to one of two treatment groups:
- Group 1 participants will follow a drug conservation (DC) regimen in which ART will be stopped or deferred until CD4 cell count drops below 250 cells/mm3, will be initiated until CD4 cell count is at least 350 cells/mm3, and then will be followed by episodic ART based on CD4 cell count.
- Group 2 participants will follow a viral suppression (VS) regimen in which ART is continued to keep viral loads as low as possible, regardless of CD4 cell count.
The purpose of this study is to compare how the DC and VS regimens affect HIV transmission risk behavior among SMART study participants.
At baseline, participants will complete a questionnaire about their sexual behavior during the previous 2 months. They will also undergo urine and blood collection for STI testing. These same procedures will occur at Months 4 and 12, then every year thereafter for the first 4 years that a participant is in the parent study. Participants and their physicians will be notified of STI testing results so that patients can be referred to appropriate care.
연구 유형
등록 (실제)
연락처 및 위치
연구 장소
-
-
California
-
Beverly Hills, California, 미국, 90211
- AIDS Healthcare Foundation CRS
-
Fresno, California, 미국, 93702
- UCSF, Fresno, School of Medicine, Dept. of Internal Medicine CRS
-
Mill Valley, California, 미국, 94941-3013
- Dr. M. Estes Med. Practice CRS
-
Oakland, California, 미국, 94609
- Dr. Robert Scott Med. Practice CRS
-
Oakland, California, 미국, 94609
- East Bay AIDS Ctr. CRS
-
San Francisco, California, 미국, 94114
- Castro-Mission Health Ctr. CRS
-
San Francisco, California, 미국, 94102
- Dr. Shawn Hassler Med. Practice CRS
-
San Francisco, California, 미국, 94110
- Positive Health Program Clinic (San Francisco Gen. Hosp.) CRS
-
San Francisco, California, 미국, 94114-1010
- Dr. Virginia Cafaro Med. Practice CRS
-
San Francisco, California, 미국, 94114-1010
- Dr. William Owen Med. Practice CRS
-
San Francisco, California, 미국, 94121
- San Francisco VAMC, Infectious Diseases Clinic CRS
-
San Francisco, California, 미국, 94143
- UCSF PHP, Gen. Internal Medicine Practice CRS
-
-
Colorado
-
Boulder, Colorado, 미국, 80501-4507
- Beacon Clinic at Boulder CRS
-
Denver, Colorado, 미국, 80204-4507
- Univ. of Colorado Health Science Ctr. CRS
-
Denver, Colorado, 미국, 80205
- Eastside Family Health Ctr. CRS
-
Denver, Colorado, 미국, 80204
- Denver Public Health CRS
-
Denver, Colorado, 미국, 80204-4507
- Denver Infectious Diseases Consultants CRS
-
Denver, Colorado, 미국, 80204-4507
- Kaiser Permanente of Denver CRS
-
Denver, Colorado, 미국, 80204
- Denver Public Health CRS - INSIGHT
-
Denver, Colorado, 미국, 80220
- Denver VAMC CRS
-
Wheat Ridge, Colorado, 미국, 80033
- Western Infectious Disease Consultants CRS
-
-
District of Columbia
-
Washington, District of Columbia, 미국, 20422
- Washington DC VAMC, Washington Regional AIDS Program, Infectious Diseases CRS
-
-
Florida
-
Miami, Florida, 미국, 33125
- Miami VAMC CRS
-
-
Georgia
-
Decatur, Georgia, 미국, 30033
- Atlanta VAMC CRS
-
-
Michigan
-
Detroit, Michigan, 미국, 48201
- Wayne State Univ. CRS
-
Detroit, Michigan, 미국, 48201
- Harper Hosp., Detroit CRS
-
Detroit, Michigan, 미국, 48201
- Wayne State Univ. INSIGHT CRS
-
Detroit, Michigan, 미국, 48215
- Detroit Community Health Connection, Inc. CRS
-
Grand Rapids, Michigan, 미국, 49503
- McAuley Health Ctr. CRS
-
-
New Jersey
-
Camden, New Jersey, 미국, 08103
- Cooper Univ. Hosp. CRS
-
Camden, New Jersey, 미국
- Cooper Hospital/Univ. Med. Ctr., The Cooper Early Intervention Program (EIP) CRS
-
Newark, New Jersey, 미국, 07103
- New Jersey Medical School- Adult Clinical Research Ctr. CRS
-
Somers Point, New Jersey, 미국, 08244
- South Jersey Infectious Disease, Cape Clinical Trials CRS
-
Voorhees, New Jersey, 미국, 08043
- The Early Intervention Program at Kennedy Hosp. CRS
-
-
New York
-
Bronx, New York, 미국, 10457
- Bronx-Lebanon Hosp. Ctr. CRS
-
Bronx, New York, 미국, 10452
- Bronx Prevention Center CRS
-
Bronx, New York, 미국, 10467
- Montefiore Med. Ctr., AIDS Ctr. CRS
-
New York, New York, 미국, 10011
- St. Vincent Hosp. & Med. Ctr. CRS
-
-
Oregon
-
Eugene, Oregon, 미국, 97401
- PeaceHealth Med. Group - Hilyard Street Clinic CRS
-
Portland, Oregon, 미국, 97227
- Kaiser Immune Deficiency Clinic of Portland CRS
-
Portland, Oregon, 미국, 97239
- Oregon Health & Sciences Univ. Internal Medicine (L-475) CRS
-
Portland, Oregon, 미국, 97210
- The Research & Education Group-Portland CRS
-
Portland, Oregon, 미국, 97204
- Multnomah County Health Dept., HIV Health Services Ctr. CRS
-
Portland, Oregon, 미국, 97210
- Legacy Clinic Good Samaritan CRS
-
Portland, Oregon, 미국, 97213
- Providence Portland Med. Ctr., Ambulatory Care and Education Ctr. CRS
-
Portland, Oregon, 미국, 97227
- Legacy Clinic Emanuel CRS
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, 미국, 19140
- Temple Univ. School of Medicine CRS
-
Philadelphia, Pennsylvania, 미국, 19107
- Philadelphia FIGHT - Dr. Jay Kostman CRS
-
Philadelphia, Pennsylvania, 미국, 19141
- Albert Einstein Med. Ctr., Immunodeficiency Ctr. CRS
-
-
Virginia
-
Fredericksburg, Virginia, 미국, 22401
- MediCorp, Infectious Disease Associates CRS
-
Mechanicsville, Virginia, 미국, 23116
- Hanover Med. Park (Mechanicsville, VA) CRS
-
Norfolk, Virginia, 미국, 23507
- Eastern Virginia Med. School, Ctr. for the Comprehensive Care of Immune Deficiency CRS
-
Petersburg, Virginia, 미국, 23803
- Petersburg Health Care Alliance CRS
-
Richmond, Virginia, 미국, 23224
- CrossOver Health Ctr. CRS
-
Richmond, Virginia, 미국, 23224
- South Richmond Health Care Ctr. CRS
-
Richmond, Virginia, 미국, 23249
- Hunter Holmes McGuire VAMC CRS
-
Richmond, Virginia, 미국, 23298
- VCU Health Systems, Infectious Disease Clinic CRS
-
Richmond, Virginia, 미국, 23223
- Vernon Harris East End Community Health Ctr. CRS
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
샘플링 방법
연구 인구
설명
Inclusion Criteria:
- Coenrollment in the SMART study
- Parent or guardian willing to provide informed consent, if applicable
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
코호트 및 개입
그룹/코호트 |
개입 / 치료 |
---|---|
1: DC Group
HIV infected participants who will stop or defer ART until the CD4 cell count drops below 250 cells/mm3 and who discontinue ART when CD4 cell count reaches above 350 cells/mm3.
Participants are followed by episodic ART based on CD4 cell count.
|
Participants follow a drug conservation (DC) regimen in which ART is stopped or deferred until CD4 cell count dropped below 250 cells/mm3, initiated until CD4 cell count is at least 350 cells/mm3, and then are followed by episodic ART based on CD4 cell count.
|
2: VS Group
HIV infected participants who continue ART to keep viral loads as low as possible, regardless of CD4 cell count.
|
Group 2 participants follow a viral suppression (VS) regimen in which ART was continued to keep viral loads as low as possible, regardless of CD4 cell count.
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
기간 |
---|---|
To compare the DC group to the VS group for HIV transmission and risk behaviors
기간: At the end of study
|
At the end of study
|
2차 결과 측정
결과 측정 |
기간 |
---|---|
To compare the VS group to the DC group on HIV transmission risk behavior in participants who are not on ART at enrollment
기간: At the end of study
|
At the end of study
|
To compare the effects of continuing ART in the VS group to stopping ART in the DC group on HIV transmission risk behavior among participants who are on ART at enrollment
기간: At the end of study
|
At the end of study
|
To evaluate the correlation between self-reported adherence to ART and HIV transmission risk behavior for participants on ART
기간: At the end of study
|
At the end of study
|
To compare the DC and VS groups for HIV transmission risk behavior in subgroups defined by age, gender, possible transmission category, HIV RNA level, and baseline genotypic resistance pattern.
기간: At the end of study
|
At the end of study
|
To evaluate the correlation between self-reported transmission risk behavior and the acquisition of certain sexually transmitted diseases as specified in the protocol.
기간: At the end of study
|
At the end of study
|
To develop analytic techniques to combine behavioral and biological data into a measure of overall transmission risk
기간: At the end of study
|
At the end of study
|
공동 작업자 및 조사자
수사관
- 연구 의자: Wafaa El-Sadr, MD, MPH, Harlem AIDS Treatment Group, Harlem Hospital Center
- 연구 의자: James Neaton, PhD, CPCRA Statistical and Data Management Center/CCBR
간행물 및 유용한 링크
일반 간행물
- Bunnell R, Ekwaru JP, Solberg P, Wamai N, Bikaako-Kajura W, Were W, Coutinho A, Liechty C, Madraa E, Rutherford G, Mermin J. Changes in sexual behavior and risk of HIV transmission after antiretroviral therapy and prevention interventions in rural Uganda. AIDS. 2006 Jan 2;20(1):85-92. doi: 10.1097/01.aids.0000196566.40702.28.
- Kozal MJ, Amico KR, Chiarella J, Schreibman T, Cornman D, Fisher W, Fisher J, Friedland G. Antiretroviral resistance and high-risk transmission behavior among HIV-positive patients in clinical care. AIDS. 2004 Nov 5;18(16):2185-9. doi: 10.1097/00002030-200411050-00011.
- Remien RH, Halkitis PN, O'Leary A, Wolitski RJ, Gomez CA. Risk Perception and sexual risk behaviors among HIV-positive men on antiretroviral therapy. AIDS Behav. 2005 Jun;9(2):167-76. doi: 10.1007/s10461-005-3898-7.
연구 기록 날짜
연구 주요 날짜
연구 시작
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (추정)
연구 기록 업데이트
마지막 업데이트 게시됨 (추정)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .
HIV 감염에 대한 임상 시험
-
Hospital Clinic of Barcelona완전한
-
CDC FoundationGilead Sciences알려지지 않은
-
University of WashingtonNational Institute of Mental Health (NIMH)모병
-
University of Minnesota빼는HIV 감염 | HIV/에이즈 | 에이즈 | 보조기구 | 에이즈/HIV 문제 | 에이즈와 감염미국
-
French National Agency for Research on AIDS and...Elizabeth Glaser Pediatric AIDS Foundation완전한파트너 HIV 테스트 | 부부 에이즈 상담 | 커플커뮤니케이션 | HIV 발병률카메룬, 도미니카 공화국, 그루지야, 인도
-
Michael HoelscherClinton Health Access Initiative Inc.; Instituto Nacional de Saúde (INS), Ministério da... 그리고 다른 협력자들모집하지 않고 적극적으로HIV, 신생아 HIV 조기 진단(EID), 현장 진료 검사(PoC)모잠비크, 탄자니아
-
Allegheny Singer Research Institute (also known...모집하지 않고 적극적으로
-
Erasmus Medical Center모집하지 않고 적극적으로
-
National Institute of Allergy and Infectious Diseases...Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)완전한
-
Erasmus Medical Center모병
Delayed ART에 대한 임상 시험
-
Fred Hutchinson Cancer CenterNational Institute on Drug Abuse (NIDA); University of Washington; Seattle Children's Hospital 그리고 다른 협력자들완전한
-
Institute of Tropical Medicine, BelgiumUniversity Hospital, Ghent; Universitair Ziekenhuis Brussel; Agentschap voor Innovatie door... 그리고 다른 협력자들완전한
-
Tang-Du HospitalZhejiang University; Chipscreen Biosciences, Ltd.; First Affiliated Hospital of Guangxi Medical...알려지지 않은
-
University of WashingtonBill and Melinda Gates Foundation완전한
-
Equip, LesothoUnited States Agency for International Development (USAID); Elizabeth Glaser Pediatric... 그리고 다른 협력자들알려지지 않은
-
Asahi Kasei Pharma Corporation완전한
-
Seoul National University Hospital알려지지 않은